In the context of AP, a randomized, blinded trial showed no benefit of selenium supplementation on clinical outcomes after a 90-day follow-up [165], and additional studies reported only modest biochemical improvements, such as increased GPx and decreased MDA activity, without consistent changes in SOD levels [166] (Table 3). Here, SOD1 is linked to alkaline phosphatase measurement.